» Authors » Kota Shimada

Kota Shimada

Explore the profile of Kota Shimada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 880
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe N, Hara Y, Nishito Y, Kounoe M, Sekiyama K, Takamasu E, et al.
Rheumatology (Oxford) . 2025 Jan; PMID: 39837478
Objectives: GCA is a granulomatous vasculitis affecting large vessels, leading to intimal occlusion accompanied by the accumulation of myofibroblasts. Histopathologically, GCA is characterized by destruction of the tunica media and...
2.
Ueda Y, Nunokawa T, Takamasu E, Okada H, Shimada K, Yokogawa N
Clin Rheumatol . 2024 Dec; 44(1):377-384. PMID: 39676129
Several studies have examined the utility of quadriceps femoris muscle biopsies for diagnosing antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We aimed to investigate the effects of glucocorticoid therapy on the...
3.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M, et al.
Biomark Insights . 2024 Dec; 19:11772719241297171. PMID: 39640205
Background: Rheumatoid arthritis (RA) is complicated with interstitial lung disease (ILD). Gastroesophageal reflux disease is prevented by infection and is a predisposing factor for idiopathic pulmonary fibrosis. However, the prevalence...
4.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M, et al.
J Clin Med . 2024 Nov; 13(22). PMID: 39597905
A common complication in patients with rheumatoid arthritis (RA) is interstitial lung disease (ILD). Antibodies (Abs) to anti-aminoacyl-transfer ribonucleic acid synthetase (ARS) are linked to ILD in patients with idiopathic...
5.
Takamasu E, Yokogawa N, Furukawa H, Oka S, Shimada K
Clin Rheumatol . 2024 Oct; 43(12):4009-4011. PMID: 39436591
No abstract available.
6.
Takaoka H, Miyamura T, Shimada K
SAGE Open Med . 2024 Sep; 12:20503121241277498. PMID: 39315386
Objectives: There is a lack of indicators to distinguish between interleukin-6 inhibitors responders and tumor necrosis factor inhibitors responders in the treatment of rheumatoid arthritis. Osteoporosis is a complication of...
7.
Terashima Y, Takamasu E, Shimada K
Gastro Hep Adv . 2024 Aug; 3(5):684-685. PMID: 39165428
No abstract available.
8.
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, et al.
Rheumatology (Oxford) . 2024 Aug; PMID: 39110542
Objectives: Rheumatoid arthritis (RA) is sometimes complicated by interstitial lung disease (ILD) with a poor prognosis. A single nucleotide variant (SNV) in MUC5B was associated with ILD in European RA...
9.
Takamasu E, Yokogawa N, Okada H, Morishima R, Shimada K
Eur J Intern Med . 2024 Feb; 123:153-155. PMID: 38302405
No abstract available.
10.
Nogi S, Oka S, Higuchi T, Furukawa H, Shimada K, Azuma T, et al.
RMD Open . 2024 Jan; 10(1). PMID: 38253597
Objective: The hallmarks of the chronic inflammatory disease polymyalgia rheumatica (PMR) include pain, and morning stiffness in areas of the neck, shoulder and pelvic girdle. The human leucocyte antigen ()...